Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS2009 in Advanced Solid Tumors
NCT06741644Phase 2Recruiting
- Sponsor
- CStone Pharmaceuticals
- Start
- Feb 2025
- Primary completion
- Jan 2027
- Modality
- Prophylactic Vaccines, Antibody Conjugates, Therapeutic Vaccines
- Countries
- 3
01
Overview
A Phase 2 trial of CS2009 in solid tumor (advanced stage), sponsored by CStone Pharmaceuticals. Started Feb 2025; status: recruiting.
02
Drugs
CS2009
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06741644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06741644.